Nuvalent (NUVL) Shares Outstanding (2020 - 2026)
Nuvalent (NUVL) reported Shares Outstanding of $73.4 million for Q1 2026, up 1251.32% on a YoY basis from $5.4 million in Q1 2025, and up 0.88% quarter-over-quarter from $72.8 million in Q4 2025.
Nuvalent (NUVL) Shares Outstanding (2020 - 2026) Analysis & Trends
Nuvalent has reported Shares Outstanding for 7 years, with the latest figure at $73.4 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding rose 1251.32% year-over-year to $73.4 million; the trailing twelve-month figure through Mar 2026 stood at $73.4 million (up 1251.32% YoY), and the FY2025 full-year result was $72.8 million, up 1239.48% from the prior year.
- Shares Outstanding for Q1 2026 stood at $73.4 million, up from $72.8 million in the prior quarter.
- The five-year high for Shares Outstanding was $66.3 million in Q1 2025, with the low at $5.4 million in Q3 2022.
- Historically, Shares Outstanding has averaged $38.1 million across 5 years, with a median of $51.2 million in 2022.
- Annual changes were most pronounced in 2022 — Shares Outstanding soared 1270.93% — and 2024, when it sank 90.73%.
- Nuvalent's Shares Outstanding stood at $5.4 million in 2022, then jumped by 978.7% to $58.6 million in 2023, then slumped by 90.73% to $5.4 million in 2024, then surged by 1239.48% to $72.8 million in 2025, then advanced by 0.88% to $73.4 million in 2026.
- The last three Shares Outstanding figures came in at $73.4 million (Q1 2026), $72.8 million (Q4 2025), and $66.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 91.57 Bn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Nuvalent | 9.70 Bn | 9.70 Bn | - | 5.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.44 Mn |
| Mar 31, 2026 | 5.44 Mn |
| Mar 31, 2026 | 5.44 Mn |
| Mar 31, 2026 | 5.44 Mn |
| Mar 31, 2026 | 73.45 Mn |
| Mar 31, 2026 | 73.45 Mn |
| Mar 31, 2026 | 73.45 Mn |
| Mar 31, 2026 | 73.45 Mn |
| Dec 31, 2025 | 5.44 Mn |
| Dec 31, 2025 | 72.80 Mn |
| Dec 31, 2025 | 72.80 Mn |
| Dec 31, 2025 | 72.80 Mn |
| Dec 31, 2025 | 72.80 Mn |
| Dec 31, 2025 | 5.44 Mn |
| Dec 31, 2025 | 5.44 Mn |
| Dec 31, 2025 | 5.44 Mn |
| Sep 30, 2025 | 66.84 Mn |
| Sep 30, 2025 | 5.44 Mn |
| Sep 30, 2025 | 5.44 Mn |
| Sep 30, 2025 | 5.44 Mn |